Dr. Nathan Christopher Sheets, MD

Dr. Sheets practices at Sentara Obici Hospital in Suffolk, Virginia, part of Sentara Health.

Dr. Sheets' NPI, 1477788263, was assigned on May 21, 2009. Dr. Sheets graduated from University of Michigan Medical School in 2008. Dr. Sheets holds North Carolina license 2010-01742.

Dr. Sheets' primary practice is Sentara Obici Hospital, at 2800 Godwin Boulevard, Suffolk, VA 23434 in Suffolk City. The practice phone is (757) 934-4000.

Dr. Sheets' primary practice is Sentara Obici Hospital in Suffolk, Virginia, part of Sentara Health. Dr. Sheets is also affiliated with Sentara Norfolk General Hospital. The medical group on file is EVMS Medical Group. Dmand AI also links Dr. Sheets to 2 more hospitals, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheets practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sheets' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Sheets' licenses on file in 2 states: North Carolina and Virginia.

CMS data shows 1,861 Medicare services from Dr. Sheets across 13 procedure codes in 2024, for 199 Medicare patients. Medicare paid $135,409 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 199 Medicare patients who saw Dr. Sheets in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheets' median patient age at 68, with 55% women.

In 2024, Dr. Sheets wrote 88 Medicare Part D claims for 38 patients. 92% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $236 in total drug cost. In 2022, CMS named 13 claims across 1 drug.

Dr. Sheets accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Sheets, published from 2012 to 2023. 2018 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Radiotherapy, Intensity-Modulated and Oropharyngeal Neoplasms. Dr. Sheets has published most often in Int J Radiat Oncol Biol Phys. Dr. Sheets' most frequent co-authors are Bhishamjit Singh Chera, MD, Robert J. Amdur, MD and William M. Mendenhall, MD.

Dmand AI links Dr. Sheets to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 12 general payments to Dr. Sheets from 8 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. RefleXion Medical, Inc. paid the most, $156.

Dr. Sheets graduated from University of Michigan Medical School in 2008.